UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification

Tattum, MH; Jones, S; Pal, S; Collinge, J; Jackson, GS; (2010) Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion , 50 (5) 996 - 1002. 10.1111/j.1537-2995.2010.02595.x. Green open access

[thumbnail of Tattum_et_al_Discrimination_between_prion-infected_PMCA.pdf] PDF
Tattum_et_al_Discrimination_between_prion-infected_PMCA.pdf

Download (595kB)

Abstract

BACKGROUND:Diagnosis of prion disease from blood samples requires the detection of minute quantities of misfolded protein (PrPSc) against a high background of correctly folded material (PrPC). Protein misfolding cyclic amplification (PMCA) is a technique that can amplify small amounts of seed PrPSc to a level detectable by conventional methods. Application of PMCA to the testing of whole blood samples enhances the ability to detect PrPSc and allows antemortem detection of prion infection and could facilitate blood screening.STUDY DESIGN AND METHODS:The PMCA method was used to detect prion infection in blood samples obtained from mice experimentally infected with prion disease. Mice were culled at various time points throughout the incubation period for disease and subjected to serial PMCA (sPMCA). Amplified samples were then analyzed by Western blotting to confirm the presence or absence of infection.RESULTS:After sPMCA, blood samples from Rocky Mountain Laboratory-infected mice showed amplification of PrPSc to levels readily detectable by Western blotting. Control samples obtained from mice mock inoculated with sterile phosphate-buffered saline did not yield any amplification products.CONCLUSION:sPMCA performed on small volumes of whole blood gave amplification of PK-resistant material to a level detectable by standard methods. Discrimination between infected and control samples was achieved without the need for processing or fractionation of whole blood. The use of whole blood as an analyte circumvents the need to identify the optimal blood compartment for analysis and guarantees the totality of misfolded PrP will be available for detection.

Type: Article
Title: Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/j.1537-2995.2010.02595.x
Publisher version: http://dx.doi.org/10.1111/j.1537-2995.2010.02595.x
Language: English
Additional information: This is the accepted version of the following article: Tattum, MH; Jones, S; Pal, S; Collinge, J; Jackson, GS; (2010) Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion , 50 (5) 996 - 1002. , which has been published in final form at http://dx.doi.org/10.1111/j.1537-2995.2010.02595.x
Keywords: Creutzfeldt-Jakob-Disease, Transmissible Spongiform Encephalopathy, In-Vitro Amplification, Scrapie, Infectivity, Transfusion, Assay, Components, Brain, Mice
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Institute of Prion Diseases
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Institute of Prion Diseases > MRC Prion Unit at UCL
URI: https://discovery.ucl.ac.uk/id/eprint/145941
Downloads since deposit
255Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item